US$ 21.98
semaglutide launch Business India GLP-1 Market Shift: Mankind
Description
Similarly, in pregnant women, certain forms or patterns of IF have been associated with adverse maternal and offspring health outcomes, including fatigue, dehydration, and potential impacts on fetal development (155, 156)
This move could cut development costs, shorten timelines, and speed patient access
Wegovys use for weight loss has already caused issues with availability for diabetes patients and the cost of the drug is also potentially prohibitive
At this stage, healthy eating habits may start to feel easier to maintain
The relationship between dose and response in humans is unknown
